# OSELTAMIVIR PHOSPHATE
> **ANDA214949** · Abbreviated New Drug Application (Generic) · Sponsor: LEADING · Approved 2022-02-28
## Drug
- **FDA Application Number:** ANDA214949
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** OSELTAMIVIR PHOSPHATE
- **Generic name:** OSELTAMIVIR PHOSPHATE
- **Active ingredients:** OSELTAMIVIR PHOSPHATE
- **Dosage form:** FOR SUSPENSION
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** LEADING
- **Manufacturer:** Leading Pharma, LLC
- **First approval:** 2022-02-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214949)
---
*AI Analytics · CC0 1.0*